Cargando…
Datasets for the validation of the "in vivo" siRNA-silencing of CD40 and for the detection of new markers of atherosclerosis progression in ApoE-deficient mice
Data presented in this Data in Brief article correspond to the article "in vivo" silencing of CD40 reduces progression of experimental atherogenesis through a NFκB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis" (M. Hueso, L. De Ramon, E. Nava...
Autores principales: | Hueso, Miguel, De Ramon, Laura, Navarro, Estanislao, Ripoll, Elia, Cruzado, Josep M., Grinyo, Josep M., Torras, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128022/ https://www.ncbi.nlm.nih.gov/pubmed/27924297 http://dx.doi.org/10.1016/j.dib.2016.11.045 |
Ejemplares similares
-
The double edge of anti-CD40 siRNA therapy: It increases renal microcapillar density but favours the generation of an inflammatory milieu in the kidneys of ApoE(−/−) mice
por: Hueso, Miguel, et al.
Publicado: (2019) -
siRNA-silencing of CD40 attenuates unilateral ureteral obstruction-induced kidney injury in mice
por: Narváez, Alonso, et al.
Publicado: (2019) -
ALUminating the Path of Atherosclerosis Progression: Chaos Theory Suggests a Role for Alu Repeats in the Development of Atherosclerotic Vascular Disease
por: Hueso, Miguel, et al.
Publicado: (2018) -
Unveiling ncRNA regulatory axes in atherosclerosis progression
por: Navarro, Estanislao, et al.
Publicado: (2020) -
CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms
por: Ripoll, Èlia, et al.
Publicado: (2013)